Kaja Michalczyk

ORCID: 0000-0002-1237-681X · 5 papers in corpus
2023
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics13030452

HE4 is a commonly used tumor marker for ovarian cancer (OC) diagnosis. In our study, we aimed to assess its use in the diagnosis of subsequent OC recurrences and to evaluate its changes during recurrence diagnosis and the subsequent lines o…

2021
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics11040626

The aim of our research was to determine the use of CA125 and HE4 as prognostic factors in patients with different clinical staging of endometrial cancer. Sixty-two patients with advanced endometrial cancer and 287 patients with early stage…

article 2021
International journal of environmental research and public health ·doi:10.3390/ijerph18158177

Endometriosis is a chronic disease of unclear aetiology that affects millions of women around the world. It causes chronic pain, dysmenorrhea, and infertility, which significantly reduces the quality of daily life. The aim of the following …

2021
International journal of molecular sciences ·doi:10.3390/ijms222212472

Endometrial cancer is one of the most common gynecological malignancies, yet the molecular mechanisms that lead to tumor development and progression are still not fully established. Matrix metalloproteinases (MMPs) are a group of enzymes th…

review 2021
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics11030494

Endometrial cancer is one of the most frequently diagnosed gynecological neoplasms in developed countries and its incidence is rising. Usually, it is diagnosed in the early stages of the disease and has a good prognosis; however, in later s…